CHS INC - CHSINC 8 PERP (CHSCP) Fundamental Analysis & Valuation
NASDAQ:CHSCP • US12542R2094
Current stock price
27.62 USD
-0.01 (-0.04%)
Last:
This CHSCP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CHSCP Profitability Analysis
1.1 Basic Checks
- CHSCP had a positive operating cash flow in the past year.
- In the past 5 years CHSCP has always been profitable.
- Each year in the past 5 years CHSCP had a positive operating cash flow.
1.2 Ratios
- CHSCP has a Return On Assets of 2.96%. This is comparable to the rest of the industry: CHSCP outperforms 56.32% of its industry peers.
- With a Return On Equity value of 5.48%, CHSCP perfoms like the industry average, outperforming 56.32% of the companies in the same industry.
- CHSCP has a Return On Invested Capital of 0.37%. This is comparable to the rest of the industry: CHSCP outperforms 40.23% of its industry peers.
- CHSCP had an Average Return On Invested Capital over the past 3 years of 3.89%. This is below the industry average of 7.23%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.96% | ||
| ROE | 5.48% | ||
| ROIC | 0.37% |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
1.3 Margins
- CHSCP has a Profit Margin (1.75%) which is in line with its industry peers.
- In the last couple of years the Profit Margin of CHSCP has grown nicely.
- With a Operating Margin value of 0.21%, CHSCP is not doing good in the industry: 62.07% of the companies in the same industry are doing better.
- CHSCP's Operating Margin has declined in the last couple of years.
- The Gross Margin of CHSCP (3.21%) is worse than 85.06% of its industry peers.
- CHSCP's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.21% | ||
| PM (TTM) | 1.75% | ||
| GM | 3.21% |
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
2. CHSCP Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHSCP is destroying value.
- The debt/assets ratio for CHSCP is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 2.11 indicates that CHSCP is not a great score, but indicates only limited risk for bankruptcy at the moment.
- CHSCP's Altman-Z score of 2.11 is in line compared to the rest of the industry. CHSCP outperforms 52.87% of its industry peers.
- A Debt/Equity ratio of 0.32 indicates that CHSCP is not too dependend on debt financing.
- The Debt to Equity ratio of CHSCP (0.32) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.11 |
ROIC/WACC0.07
WACC5.57%
2.3 Liquidity
- CHSCP has a Current Ratio of 1.42. This is a normal value and indicates that CHSCP is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of CHSCP (1.42) is comparable to the rest of the industry.
- A Quick Ratio of 0.80 indicates that CHSCP may have some problems paying its short term obligations.
- CHSCP has a Quick ratio (0.80) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.42 | ||
| Quick Ratio | 0.8 |
3. CHSCP Growth Analysis
3.1 Past
- Looking at the last year, CHSCP shows a decrease in Revenue. The Revenue has decreased by -5.74% in the last year.
- CHSCP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.54% yearly.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-4.63%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. CHSCP Valuation Analysis
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CHSCP is valued cheaply inside the industry as 93.10% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.4 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. CHSCP Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 7.20%, CHSCP is a good candidate for dividend investing.
- CHSCP's Dividend Yield is rather good when compared to the industry average which is at 2.45. CHSCP pays more dividend than 91.95% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.89, CHSCP pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.2% |
5.2 History
- CHSCP has paid a dividend for at least 10 years, which is a reliable track record.
- CHSCP has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years21
5.3 Sustainability
- CHSCP pays out 27.52% of its income as dividend. This is a sustainable payout ratio.
DP27.52%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCP Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:CHSCP (3/30/2026, 4:04:22 PM)
27.62
-0.01 (-0.04%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)01-06 2026-01-06
Earnings (Next)03-31 2026-03-31
Inst Owners10.86%
Inst Owner Change-0.8%
Ins Owners0.04%
Ins Owner Change0%
Market Cap338.90M
Revenue(TTM)35.03B
Net Income(TTM)613.61M
Analysts0
Price TargetN/A
Short Float %0.28%
Short Ratio1.92
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.2% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP27.52%
Div Incr Years0
Div Non Decr Years21
Ex-Date03-17 2026-03-17 (0.5)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.01 | ||
| P/FCF | N/A | ||
| P/OCF | 0.57 | ||
| P/B | 0.03 | ||
| P/tB | 0.03 | ||
| EV/EBITDA | 2.4 |
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-4.86
FCFYN/A
OCF(TTM)48.25
OCFY174.67%
SpS2855.14
BVpS913.07
TBVpS913.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.96% | ||
| ROE | 5.48% | ||
| ROCE | 0.54% | ||
| ROIC | 0.37% | ||
| ROICexc | 0.38% | ||
| ROICexgc | 0.38% | ||
| OM | 0.21% | ||
| PM (TTM) | 1.75% | ||
| GM | 3.21% | ||
| FCFM | N/A |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
ROICexc(3y)4.33%
ROICexc(5y)4.38%
ROICexgc(3y)4.41%
ROICexgc(5y)4.46%
ROCE(3y)5.12%
ROCE(5y)5.34%
ROICexgc growth 3Y-59.71%
ROICexgc growth 5Y-22%
ROICexc growth 3Y-59.75%
ROICexc growth 5Y-22.29%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
F-Score4
Asset Turnover1.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.81 | ||
| Cap/Depr | 96.64% | ||
| Cap/Sales | 1.86% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.1% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.42 | ||
| Quick Ratio | 0.8 | ||
| Altman-Z | 2.11 |
F-Score4
WACC5.57%
ROIC/WACC0.07
Cap/Depr(3y)119.46%
Cap/Depr(5y)96.76%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-4.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-77.46%
EBIT growth 3Y-56.84%
EBIT growth 5Y-20.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-102.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-82.15%
OCF growth 3Y-31.13%
OCF growth 5Y-10.17%
CHS INC - CHSINC 8 PERP / CHSCP Fundamental Analysis FAQ
What is the fundamental rating for CHSCP stock?
ChartMill assigns a fundamental rating of 3 / 10 to CHSCP.
Can you provide the valuation status for CHS INC - CHSINC 8 PERP?
ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 8 PERP (CHSCP). This can be considered as Overvalued.
Can you provide the profitability details for CHS INC - CHSINC 8 PERP?
CHS INC - CHSINC 8 PERP (CHSCP) has a profitability rating of 4 / 10.
How sustainable is the dividend of CHS INC - CHSINC 8 PERP (CHSCP) stock?
The dividend rating of CHS INC - CHSINC 8 PERP (CHSCP) is 8 / 10 and the dividend payout ratio is 27.52%.